OSE Immunotherapeutics and Servier Amend the Global Licensing Option Agreement for IL-7R Antagonist OSE-127 in Autoimmune Diseases
Under this amendment, OSE Immunotherapeutics will receive a €5 million milestone payment at the start of the Sjögren’s Phase 2... View Article
GRAFTYS ADDS A NEW DISTRIBUTION PARTNERSHIP IN THE US TERRITORY
GRAFTYS SA (“Graftys”), a global leader in resorbable bone cements, today announces a new distribution agreement for its bestselling... View Article
NEW MEMBER | WELIOM
ASSESS, ADVISE, STEER WELIOM is emerging as a partner in the reconfiguration of healthcare institutions, deploying healthcare stakeholders, recognised experts... View Article
NEW MEMBER | NUCLEOPOLIS
NUCLEOPOLIS, THE NORMANDIE ENERGIES NUCLEAR CLUSTER Nucleopolis is the Normandie Énergies nuclear cluster, a major player in the Normandy energy... View Article
NEW MEMBER | GUTY
THE SMART ASSISTANT PROVIDING CARE AND SUPPORT SERVICES FOR GASTROINTESTINAL DISORDERS AND DIGESTIVE DISEASES Guty is the leading smart solution... View Article
NEW MEMBER | ADWST
THERAPEUTIC WATER DEVELOPMENT NATARYS was created in 2007 based on the strongly held belief that providing people with access to... View Article
ABOLERIS PHARMA – CONTROLLING AUTOIMMUNE DISEASES AND TRANSPLANT REJECTIONS
ABOLERIS PHARMA, AN EMERGING COMPANY IN THE FIELD OF IMMUNOTHERAPY RESEARCH ESTABLISHED ON 28th NOVEMBER 2019, DEVELOPS PROPRIETARY MOLECULES THAT... View Article
MEETING THE CHALLENGES FACING EUROPEAN HEALTHCARE ECOSYSTEMS
In collaboration with the European Commission CEBR delivers opinions on the role and status of European life sciences ecosystems and... View Article
CE4BIG: A EUROPEAN PROJECT COORDINATED BY THE SELECTED AND FUNDED CLUSTER
In 2019, the European project CE4BIG – Cluster Excellence for Business Innovation and Growth in the Health Sector – was... View Article
RELIEF, A STRATEGIC PROJECT FOR GLIOCURE, SELECTED BY EUREKA !
Angers, 20th January 2020 – GlioCure SAS, a biotechnology company specialising in the field of neuro-oncology and a member of... View Article